Savaria (TSE:SIS) Stock Price Expected to Rise, ATB Cormark Capital Markets Analyst Says

Savaria (TSE:SIS) had its price target raised by stock analysts at ATB Cormark Capital Markets from C$32.00 to C$35.00 in a report released on Wednesday,BayStreet.CA reports. The firm currently has an “outperform” rating on the stock. ATB Cormark Capital Markets’ price objective would indicate a potential upside of 22.42% from the company’s current price.

A number of other equities research analysts also recently weighed in on SIS. Raymond James Financial boosted their target price on Savaria from C$32.00 to C$33.00 and gave the stock an “outperform” rating in a research report on Wednesday. Desjardins increased their price objective on shares of Savaria from C$27.00 to C$32.00 and gave the stock a “buy” rating in a research report on Friday, March 6th. National Bank Financial raised their price objective on Savaria from C$30.00 to C$30.50 and gave the company an “outperform” rating in a report on Friday, March 6th. Stifel Nicolaus raised their target price on shares of Savaria from C$29.00 to C$31.00 and gave the company a “buy” rating in a research note on Wednesday, April 8th. Finally, Scotiabank boosted their target price on Savaria from C$29.00 to C$30.00 and gave the stock an “outperform” rating in a report on Friday, March 6th. Nine analysts have rated the stock with a Buy rating, According to MarketBeat.com, the stock has an average rating of “Buy” and a consensus price target of C$32.61.

Savaria Trading Down 0.7%

Shares of Savaria stock opened at C$28.59 on Wednesday. The company has a 50-day simple moving average of C$26.16 and a 200 day simple moving average of C$23.74. Savaria has a 12-month low of C$16.13 and a 12-month high of C$30.41. The stock has a market capitalization of C$2.06 billion, a P/E ratio of 29.78, a price-to-earnings-growth ratio of 42.72 and a beta of 0.86. The company has a quick ratio of 0.91, a current ratio of 1.61 and a debt-to-equity ratio of 32.13.

Savaria (TSE:SIS) last released its quarterly earnings results on Wednesday, March 4th. The company reported C$0.37 earnings per share for the quarter. Savaria had a return on equity of 11.10% and a net margin of 7.53%.The firm had revenue of C$241.78 million during the quarter. Research analysts expect that Savaria will post 1.2048518 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Savaria news, insider Jean-Philippe De Montigny acquired 2,420 shares of Savaria stock in a transaction that occurred on Friday, March 20th. The shares were acquired at an average cost of C$25.50 per share, with a total value of C$61,710.00. Following the completion of the purchase, the insider directly owned 92,260 shares of the company’s stock, valued at C$2,352,630. This represents a 2.69% increase in their position. 17.45% of the stock is owned by company insiders.

Key Stories Impacting Savaria

Here are the key news stories impacting Savaria this week:

• Positive Sentiment: Desjardins raised its price target to C$35.00 and kept a “buy” rating — about a 22.8% upside from current levels. BayStreet.CA
• Positive Sentiment: Scotia raised its target to C$33.00 and set a “sector outperform” rating — ~15.7% implied upside. BayStreet.CA
• Positive Sentiment: ATB Cormark Capital Markets bumped its target to C$35.00 and kept an “outperform” call — ~21.6% upside. BayStreet.CA
• Positive Sentiment: Raymond James raised its target to C$33.00 and maintained an “outperform” rating — ~14.7% implied upside. BayStreet.CA
• Positive Sentiment: TD increased its target to C$35.00 and kept a “buy” rating — ~21.6% upside; coverage also noted on TickerReport. BayStreet.CA TickerReport

Savaria Company Profile

Savaria Corporation ( savaria.com ) is a global leader in the accessibility industry. It provides accessibility solutions for the physically challenged to increase their comfort, their mobility and their independence. Its product line is one of the most comprehensive on the market. Savaria designs, manufactures, distributes and installs accessibility equipment, such as stairlifts for straight and curved stairs, vertical and inclined wheelchair lifts and elevators for home and commercial use. It also manufactures and markets a comprehensive selection of pressure management products for the medical market, medical beds for the long-term care market, as well as an extensive line of medical equipment and solutions for the safe handling of patients, including ceiling lifts and slings.